标题
Systems biology of cisplatin resistance: past, present and future
作者
关键词
-
出版物
Cell Death & Disease
Volume 5, Issue 5, Pages e1257-e1257
出版商
Springer Nature
发表日期
2014-05-30
DOI
10.1038/cddis.2013.428
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: Molecular mechanisms unveiled by gene expression profiling
- (2013) Martin Koch et al. BIOCHEMICAL PHARMACOLOGY
- Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours
- (2013) J Mendoza et al. BRITISH JOURNAL OF CANCER
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
- (2013) Alexander Roesch et al. CANCER CELL
- Cisplatin Resistance Associated with PARP Hyperactivation
- (2013) J. Michels et al. CANCER RESEARCH
- ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
- (2013) C. J. Huntoon et al. CANCER RESEARCH
- The Hallmarks of Aging
- (2013) Carlos López-Otín et al. CELL
- Prognostic value of LIPC in non-small cell lung carcinoma
- (2013) Lorenzo Galluzzi et al. CELL CYCLE
- Vitamin B6 metabolism influences the intracellular accumulation of cisplatin
- (2013) Lorenzo Galluzzi et al. CELL CYCLE
- Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer
- (2013) Judith Michels et al. CELL CYCLE
- Crosstalk between ER stress and immunogenic cell death
- (2013) Oliver Kepp et al. CYTOKINE & GROWTH FACTOR REVIEWS
- MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells
- (2013) Fang Wang et al. FEBS LETTERS
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- ATP11B mediates platinum resistance in ovarian cancer
- (2013) Myrthala Moreno-Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma
- (2013) Yong Guo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity
- (2013) S. S. More et al. JOURNAL OF NEUROSCIENCE
- Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria
- (2013) Michaela Aichler et al. JOURNAL OF PATHOLOGY
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Integrated proteomic analysis of post-translational modifications by serial enrichment
- (2013) Philipp Mertins et al. NATURE METHODS
- ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer
- (2013) Luc Friboulet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses
- (2013) L Galluzzi et al. ONCOGENE
- miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1
- (2013) Li Zhou et al. PATHOLOGY & ONCOLOGY RESEARCH
- Identification of Cisplatin-Binding Proteins Using Agarose Conjugates of Platinum Compounds
- (2013) Takatoshi Karasawa et al. PLoS One
- The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
- (2013) Yong Yang et al. PLoS One
- MicroRNA Expression Profiling of Esophageal Cancer Before and After Induction Chemoradiotherapy
- (2012) Michael Augustine Ko et al. ANNALS OF THORACIC SURGERY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Aging, Cellular Senescence, and Cancer
- (2012) Judith Campisi Annual Review of Physiology
- Increased expression of VDAC1 sensitizes carcinoma cells to apoptosis induced by DNA cross-linking agents
- (2012) Ossama Sharaf el dein et al. BIOCHEMICAL PHARMACOLOGY
- Overexpression of IL-7 enhances cisplatin resistance in glioma
- (2012) Lei Cui et al. CANCER BIOLOGY & THERAPY
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
- (2012) Elizabeth S. Nakasone et al. CANCER CELL
- RhoJ Regulates Melanoma Chemoresistance by Suppressing Pathways That Sense DNA Damage
- (2012) H. Ho et al. CANCER RESEARCH
- Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy
- (2012) M. T. Kuo et al. CANCER RESEARCH
- Cisplatin Sensitivity Mediated by WEE1 and CHK1 Is Mediated by miR-155 and the miR-15 Family
- (2012) L. M. Pouliot et al. CANCER RESEARCH
- p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
- (2012) Angelina V. Vaseva et al. CELL
- Independent transcriptional reprogramming and apoptosis induction by cisplatin
- (2012) Lorenzo Galluzzi et al. CELL CYCLE
- Association of CASP7 Polymorphisms and Survival of Patients With Non-small Cell Lung Cancer With Platinum-Based Chemotherapy Treatment
- (2012) Ji Qian et al. CHEST
- Mitochondrial Control of Cellular Life, Stress, and Death
- (2012) Lorenzo Galluzzi et al. CIRCULATION RESEARCH
- Genome-Wide Association Study of Prognosis in Advanced Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
- (2012) L. Hu et al. CLINICAL CANCER RESEARCH
- Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid Chemoprevention
- (2012) M. A. T. Hildebrandt et al. CLINICAL CANCER RESEARCH
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
- (2012) Sergio Marchini et al. EUROPEAN JOURNAL OF CANCER
- Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144
- (2012) Idoia G. Zubeldia et al. EXPERIMENTAL CELL RESEARCH
- Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
- (2012) Xin Fu et al. FEBS LETTERS
- Mechanism of cisplatin resistance in human urothelial carcinoma cells
- (2012) Hui-Min Yu et al. FOOD AND CHEMICAL TOXICOLOGY
- Integrated epigenomics identifiesBMP4as a modulator of cisplatin sensitivity in gastric cancer
- (2012) Tatiana Ivanova et al. GUT
- Validated gene targets associated with curatively treated advanced serous ovarian carcinoma
- (2012) Joyce N. Barlin et al. GYNECOLOGIC ONCOLOGY
- Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
- (2012) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitochondrial Proteomic Analysis of Cisplatin Resistance in Ovarian Cancer
- (2012) Nicole P. Chappell et al. JOURNAL OF PROTEOME RESEARCH
- Quantitative immunoproteomics analysis reveals novel MHC class I presented peptides in cisplatin-resistant ovarian cancer cells
- (2012) Vivekananda Shetty et al. Journal of Proteomics
- Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
- (2012) Céline Jacquemont et al. Molecular Cancer
- Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
- (2012) Siqing Fu et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the Inhibitor of Apoptosis Proteins as a Novel Therapeutic Strategy in Medulloblastoma
- (2012) J. Keating et al. MOLECULAR CANCER THERAPEUTICS
- Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents
- (2012) Z. D. Liang et al. MOLECULAR CANCER THERAPEUTICS
- Cisplatin treatment leads to changes in nuclear protein and microRNA expression
- (2012) Guanglin Zhang et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Minimizing the damage: repair pathways keep mitochondrial DNA intact
- (2012) Lawrence Kazak et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- DNA damage checkpoints in stem cells, ageing and cancer
- (2012) Tobias Sperka et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
- (2012) Bryan A. Gibson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mitochondria: master regulators of danger signalling
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Ethylene in vegetative development: a tale with a riddle
- (2012) Filip Vandenbussche et al. NEW PHYTOLOGIST
- PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations
- (2012) Z Yao et al. ONCOGENE
- RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance
- (2012) F Salm et al. ONCOGENE
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Association Between CASP8 and CASP10 Polymorphisms and Toxicity Outcomes With Platinum-Based Chemotherapy in Chinese Patients With Non-Small Cell Lung Cancer
- (2012) J. Qian et al. ONCOLOGIST
- Subcellular targets of cisplatin cytotoxicity: An integrated view
- (2012) Sandra M. Sancho-Martínez et al. PHARMACOLOGY & THERAPEUTICS
- A Head and Neck Cancer Tumor Response-Specific Gene Signature for Cisplatin, 5-Fluorouracil Induction Chemotherapy Fails with Added Taxanes
- (2012) Céline Tomkiewicz et al. PLoS One
- Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition
- (2012) Francesca Cavallo et al. PLoS One
- Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin
- (2012) L. C. Godoy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis of human DNA polymerase -mediated chemoresistance to cisplatin
- (2012) Y. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients
- (2012) Dianke Yu et al. TUMOR BIOLOGY
- Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
- (2012) Lorenzo Galluzzi et al. Cell Reports
- Loss-of-function alleles ofP2RX7andTLR4fail to affect the response to chemotherapy in non-small cell lung cancer
- (2012) Erika Vacchelli et al. OncoImmunology
- Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275
- (2011) Annette Bangert et al. ANTI-CANCER DRUGS
- Ubiquitin-proteasome genes as targets for modulation of cisplatin sensitivity in fission yeast
- (2011) Laura Gatti et al. BMC GENOMICS
- miRNA signature associated with outcome of gastric cancer patients following chemotherapy
- (2011) Chang Hee Kim et al. BMC Medical Genomics
- Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
- (2011) M Yamasaki et al. BRITISH JOURNAL OF CANCER
- Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids
- (2011) Jeanine M.L. Roodhart et al. CANCER CELL
- An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells
- (2011) Chantal Garand et al. CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
- (2011) Junjun Chen et al. CHEMISTRY & BIOLOGY
- Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non-Small Cell Lung Cancer Treated with Chemotherapy
- (2011) Y. Li et al. CLINICAL CANCER RESEARCH
- Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy
- (2011) X.-L. Tan et al. CLINICAL CANCER RESEARCH
- BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
- (2011) D. C. Marchion et al. CLINICAL CANCER RESEARCH
- p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins
- (2011) Huimei Yu et al. EUROPEAN JOURNAL OF CANCER
- Impact of cisplatin administration on protein expression levels in renal cell carcinoma: A proteomic analysis
- (2011) Radovan Vasko et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)
- (2011) Qi Wang et al. EXPERIMENTAL LUNG RESEARCH
- The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin
- (2011) Hye Sook Chon et al. GYNECOLOGIC ONCOLOGY
- Proteomic Analysis Identified DJ-1 as a Cisplatin Resistant Marker in Non-Small Cell Lung Cancer
- (2011) Hua-Zong Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer
- (2011) Jian Cheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease
- (2011) Hans Zischka et al. JOURNAL OF CLINICAL INVESTIGATION
- A new high resolution screening method for study of phenotype stress responses of Saccharomyces cerevisae mutants
- (2011) Håvard Sletta et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
- (2011) Xifeng Wu et al. JNCI-Journal of the National Cancer Institute
- Systems biology of kidney diseases
- (2011) John Cijiang He et al. KIDNEY INTERNATIONAL
- Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy
- (2011) Helen H.W. Chen et al. LUNG CANCER
- miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
- (2011) Wei Zhu et al. MEDICAL ONCOLOGY
- PGC-1 family coactivators and cell fate: Roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria–nucleus signalling
- (2011) Aleck W.E. Jones et al. MITOCHONDRION
- A Sensitized RNA Interference Screen Identifies a Novel Role for the PI3K p110 Isoform in Medulloblastoma Cell Proliferation and Chemoresistance
- (2011) A. S. Guerreiro et al. MOLECULAR CANCER RESEARCH
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Large-scale phosphosite quantification in tissues by a spike-in SILAC method
- (2011) Mara Monetti et al. NATURE METHODS
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma
- (2011) T Jiffar et al. ONCOGENE
- MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
- (2011) L Sun et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- RAB8 Enhances TMEM205-Mediated Cisplatin Resistance
- (2011) Ding-Wu Shen et al. PHARMACEUTICAL RESEARCH
- Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations
- (2011) H E Wheeler et al. PHARMACOGENOMICS JOURNAL
- A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients
- (2011) Hark Kyun Kim et al. PLoS One
- Quantitative Proteomic and Interaction Network Analysis of Cisplatin Resistance in HeLa Cells
- (2011) Juan D. Chavez et al. PLoS One
- Genome-Wide Local Ancestry Approach Identifies Genes and Variants Associated with Chemotherapeutic Susceptibility in African Americans
- (2011) Heather E. Wheeler et al. PLoS One
- Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell
- (2011) Wei Yu et al. PLoS One
- A Systematic Analysis on DNA Methylation and the Expression of Both mRNA and microRNA in Bladder Cancer
- (2011) Jialou Zhu et al. PLoS One
- Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents
- (2011) A. R. Goloudina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73
- (2010) Su Wei Wong et al. BREAST CANCER RESEARCH AND TREATMENT
- A new step ahead for the consideration of ERCC1 as a candidate biomarker to select NSCLC patients for the treatment of cetuximab in combination with cisplatin
- (2010) Ken André Olaussen CANCER BIOLOGY & THERAPY
- Acquired Cisplatin Resistance in Human Lung Adenocarcinoma Cells Is Associated with Enhanced Autophagy
- (2010) Jing-Hua Ren et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
- (2010) Seiko Ishida et al. CANCER CELL
- Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors
- (2010) M. Tanioka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
- (2010) L. Galluzzi et al. CANCER RESEARCH
- Illicit survival of cancer cells during polyploidization and depolyploidization
- (2010) I Vitale et al. CELL DEATH AND DIFFERENTIATION
- MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer
- (2010) et al. CLINICAL CANCER RESEARCH
- A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer
- (2010) Xi Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance
- (2010) Ding-Wu Shen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Platinum speciation used for elucidating activation or inhibition of Pt-containing anti-cancer drugs
- (2010) Bernhard Michalke JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
- (2010) Wyndham H Wilson et al. LANCET ONCOLOGY
- Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients
- (2010) Baohui Han et al. LUNG CANCER
- Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
- (2010) Svetlana Usanova et al. Molecular Cancer
- Autophagy and the Integrated Stress Response
- (2010) Guido Kroemer et al. MOLECULAR CELL
- Mass spectrometry in high-throughput proteomics: ready for the big time
- (2010) Tommy Nilsson et al. NATURE METHODS
- Testicular germ cell tumors: pathogenesis, diagnosis and treatment
- (2010) Christian Winter et al. Nature Reviews Endocrinology
- Molecular mechanisms of necroptosis: an ordered cellular explosion
- (2010) Peter Vandenabeele et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mitochondria and cell death: outer membrane permeabilization and beyond
- (2010) Stephen W. G. Tait et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
- (2010) I Martins et al. ONCOGENE
- Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
- (2009) N Steele et al. BRITISH JOURNAL OF CANCER
- Mirk/Dyrk1B Maintains the Viability of Quiescent Pancreatic Cancer Cells by Reducing Levels of Reactive Oxygen Species
- (2009) X. Deng et al. CANCER RESEARCH
- Mutations in the mitochondrial genome confer resistance of cancer cells to anticancer drugs
- (2009) Satoshi Mizutani et al. CANCER SCIENCE
- Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma
- (2009) W. A. Michaud et al. CLINICAL CANCER RESEARCH
- Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial
- (2009) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer
- (2009) John R. Eckardt et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer
- (2009) Giuseppe Giaccone et al. JOURNAL OF CLINICAL ONCOLOGY
- The Translesion Polymerase Rev3L in the Tolerance of Alkylating Anticancer Drugs
- (2009) W. P. Roos et al. MOLECULAR PHARMACOLOGY
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- A small-cell lung cancer genome with complex signatures of tobacco exposure
- (2009) Erin D. Pleasance et al. NATURE
- A comprehensive catalogue of somatic mutations from a human cancer genome
- (2009) Erin D. Pleasance et al. NATURE
- Mitochondrial membrane permeabilization in neuronal injury
- (2009) Lorenzo Galluzzi et al. NATURE REVIEWS NEUROSCIENCE
- REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapy
- (2009) Huibo Wang et al. NEURO-ONCOLOGY
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
- (2008) Ganna V Kalayda et al. BMC CANCER
- ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
- (2008) H J Jun et al. BRITISH JOURNAL OF CANCER
- Down-regulation of Mammalian Sterile 20-Like Kinase 1 by Heat Shock Protein 70 Mediates Cisplatin Resistance in Prostate Cancer Cells
- (2008) A. Ren et al. CANCER RESEARCH
- Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs
- (2008) Kei-ichi Ozaki et al. CANCER SCIENCE
- Patients with ERCC1-Negative Locally Advanced Esophageal Cancers May Benefit from Preoperative Chemoradiotherapy
- (2008) M. K. Kim et al. CLINICAL CANCER RESEARCH
- Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
- (2008) B. Evers et al. CLINICAL CANCER RESEARCH
- Senescence, Apoptosis or Autophagy?
- (2008) José Miguel Vicencio et al. GERONTOLOGY
- Medical Treatment of Advanced Testicular Cancer
- (2008) Darren R. Feldman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
- (2008) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
- (2008) Timothy J. Ley et al. NATURE
- ATR: an essential regulator of genome integrity
- (2008) Karlene A. Cimprich et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death
- (2008) N Tajeddine et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More